LATAM Daily Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Daily Brief.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 5, 2025

November 5, 2025

Rapport Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

November 5, 2025

Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress

GlobeNewswire

November 5, 2025

Rhythm Pharmaceuticals annonce le remboursement public de l'IMCIVREE® (setmélanotide) au Canada dans cinq provinces et dans le cadre du Programme fédéral des services de santé non assurés

GlobeNewswire

November 5, 2025

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

GlobeNewswire

November 5, 2025

Keros Therapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Huazolo Aphrodites by Cynthia Gomez Wins Silver in A' Fashion Design Awards

EIN Presswire

November 5, 2025

Enjoei Headquarter by Gema Arquitetura Wins Silver in A' Interior Design Awards

EIN Presswire

November 5, 2025

Blazpay Referral Program Goes Live – Earn 10% USDT Rewards in 2025’s Best Crypto Presale!

GlobeNewswire

November 5, 2025

Perú Mucho Gusto Lima 2025: Showcasing Peru’s Culinary Power Across 25 Regions

GlobeNewswire

November 5, 2025

Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025

GlobeNewswire

November 5, 2025

Volaris Reports October 2025 Traffic Results: Load Factor of 86%

GlobeNewswire

November 5, 2025

Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 5, 2025

Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors

GlobeNewswire

November 5, 2025

Nuvini Posts Capital Markets Update Webcast with Management Transcript

GlobeNewswire

November 5, 2025

Kailera Therapeutics to Participate in Upcoming November Investor Conferences

GlobeNewswire

November 5, 2025

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London

GlobeNewswire

November 5, 2025

Fundación TAO llama a priorizar detección de cáncer de próstata en México

EIN Presswire

November 5, 2025

Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights

GlobeNewswire

November 5, 2025

Altimmune to Participate in Two Upcoming Investor Conferences

GlobeNewswire